Anticoagulants & antiplatelets Flashcards
What are the 2 main classes of anticoagulant drugs
Warfarin
Heparin
Warfarin: Mechanism of action Indications for use Pharmacokinetics ADRs
Vitamin K competitive antagonist: prevents production of vitamin K depending clotting factors: II/prothrombin, VII, IX, X)
Used in DVT, PE, AF, mechanical prosthetic hear valves
Good GI absorption, so given Orally
Preferred from long term anti-coagulation
Slow onset and offset of action
Heavily protein bound and can be displaced to have greater effect (e.g. With albumin)
Metabolised via CYP so affected by inducers and inhibitors
Dose monitoring via INR
ADRs: haemorrhage (esp GI), bruising, teratogenic
What is INR
International normalised ratio
time taken for blood to clot
high = poor clotting
Aim 2-3 for DVT, PE,AF
What are the main drugs potentiating and inhibiting warfarin
Potentiating (increase INR)
Inhibit hepatic metab (amiodarone, quinolone, cimetidine, alcohol, metroniazole)
Inhibit platelet function (aspirin)
Reduce vitamin K From gut bacteria (cephalosporin)
Inhibiting (reduce INR)
Antiepileptics
Rifampicin
St john’s wort, grapefruit juice
How is warfarin overdose treated
Warfarin a competitive vitamin K antagonists: so can be displaced by excessive vitamin K (slowly)
Faster reversal: fresh frozen plasma: activate clotting factors
Heparin: Main Mechanism of action 2 subdivisions Indications ADRs
Acts on anti-thrombin III to inhibit mainly clotting factor II (thrombin) and Xa
Subdivided into unfractionsted and low molecular weight heparin
LMWH usually preferred in prophylaxis of venous thromboembolism because lower risk thrombocytopenia
Also used in DVT, PE (prior to warfarin to cover whilst loading dose achieved), MI, unstable coronary artery disease
Used in surgery as has faster offset than warfarin
ADRs: haemorrhage, thrombocytopenia (autoimmune: activation of more platelets, depletion of platelets and thrombosis)
What are the main differences between unfractionated and LMW heparin
UFH:
Non-linear dose response, unpredictable binding to cells (variable bioavailibility), needs monitoring with APTT test
LMWH:
Predictable dose response, less binding to cells and endothelium (predictible bioavailibility), not monitoring required
What are the 2 types of anti-platelets
Give some examples
Thromboxane A2 inhibitors
E.g. Aspirin, dipyridamole
Platelet ADP-receptor antagonists
E.g. Clopidogrel
How does aspirin work as an anti-platelet
COX enzyme inhibitor
Prevents thromboxane A2 production and platelet aggregation
How does dipyridamole work as an anti-platelet
Inhibits phosphodiesterase enzymes to inhibit thromboxane A2 production
What are the reasons for thrombus formation
Virchov’s triad:
Abnormality of vessel wall (endothelial damage e.g. Atheroma, htn)
Abnormality to blood constituents (hypercoagulability: genetic or acquired e.g. Smoking)
Abnormality to blood flow (stasis: e.g. Immobility, AF)